AI Science Tracker
EN

3D CT-Inclusive Deep-Learning Model to Predict Mortality, ICU Admittance, and Intubation in COVID-19 Patients.

Affiliation not stated in the reviewed material · 30 Nov 2022 · medicine

Discovery

3D CT-Inclusive Deep-Learning Model to Predict Mortality, ICU Admittance, and Intubation in COVID-19 Patients.

Source check: Source checked. Not independent scientific confirmation.

Finding: Full Springer PDF: 3D CT model trained/evaluated on Italian hospital cohorts for mortality, ICU and intubation; external validation reported. CT-only mortality sensitivity was low (about 28%); adding clinical features raised performance, so the result is narrow and cohort-specific. The admission is restricted to this measured result and study setting; it is not evidence of deployment benefit.

Technology: Full Springer PDF: 3D CT model trained/evaluated on Italian hospital cohorts for mortality, ICU and intubation; external validation reported. CT-only mortality sensitivity was low (about 28%); adding clinical features raised performance, so the result is narrow and cohort-specific.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Full Springer PDF: 3D CT model trained/evaluated on Italian hospital cohorts for mortality, ICU and intubation; external validation reported. CT-only mortality sensitivity was low (about 28%); adding clinical features raised performance, so the result is narrow and cohort-specific
Test and result
Full Springer PDF: 3D CT model trained/evaluated on Italian hospital cohorts for mortality, ICU and intubation; external validation reported. CT-only mortality sensitivity was low (about 28%); adding clinical features raised performance, so the result is narrow and cohort-specific
Limitation / still unknown
Full Springer PDF: 3D CT model trained/evaluated on Italian hospital cohorts for mortality, ICU and intubation; external validation reported. CT-only mortality sensitivity was low (about 28%); adding clinical features raised performance, so the result is narrow and cohort-specific
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://link.springer.com/article/10.1007/s10278-022-00734-4 · https://link.springer.com/content/pdf/10.1007/s10278-022-00734-4.pdf · https://api.crossref.org/works/10.1007%2Fs10278-022-00734-4

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.